Literature DB >> 12037677

STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells.

Cheng-Yong Yu1, Lihua Wang, Alexander Khaletskiy, William L Farrar, Andrew Larner, Nancy H Colburn, Jian Jian Li.   

Abstract

STAT3, a member of signal transducers and activators of transcription (STATs) originally discovered as mediators in cytokine signaling pathways, plays an active role in oncogenesis. However, the function of STAT3 in signaling multistage carcinogenesis, especially in transformation of tumor-promotion sensitive epithelial cells has not been elucidated. The present study demonstrates that STAT3 is activated in interleukin-6 induced transformation in mouse skin epithelial cells. DNA binding and transcriptional activities of STAT3 were significantly increased by interleukin-6. This induced anchorage-independent transformation in tumor-promotion sensitive JB6 mouse skin P+ cells but not in the resistant variant P- cells. Two forms of dominant negative STAT3 (mutant of transcriptional domain, mF, or DNA-binding domain, mD) were stably transfected into P+ cells. Activation of STAT3 was abolished and importantly, interleukin-6 induced anchorage-independent growth was absent in both mutant STAT3 transfectants. To determine the genes targeted by STAT3, three matrix metalloproteinase proteins linked with carcinogenesis of epithelial cells were analysed. Both basal and interleukin-6 induced expression of collagenase I and stromelysin I, but not gelatinase A, were inhibited in the mutant STAT3 transfectants. Furthermore, transfection of a wild type STAT3 restored STAT3 transactivation and response to interleukin-6 induced transformation in mutant STAT3 transfectants, which up-regulated collagenase I and stromelysin I as well. Together, these results provide the first evidence that STAT3 activation is required in the progression of multistage carcinogenesis of mouse skin epithelial cells, and matrix metalloproteinases are actively involved in STAT3-mediated cell transformation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12037677     DOI: 10.1038/sj.onc.1205499

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Role of NEK6 in tumor promoter-induced transformation in JB6 C141 mouse skin epidermal cells.

Authors:  Young Jin Jeon; Kun Yeong Lee; Yong-Yeon Cho; Angelo Pugliese; Hong Gyum Kim; Chul-Ho Jeong; Ann M Bode; Zigang Dong
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

2.  Parametrial fat tissue from high fat diet-treated SKH-1 mice stimulates transformation of mouse epidermal JB6 cells.

Authors:  Jamie J Bernard; You-Rong Lou; Qing-Yun Peng; Tao Li; Priyal R Vakil; Ning Ding; Jeffrey D Laskin; Zigang Dong; Allan H Conney; Yao-Ping Lu
Journal:  J Carcinog Mutagen       Date:  2014-07-31

3.  Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer.

Authors:  Lanxi Song; Matthew A Smith; Parul Doshi; Kate Sasser; William Fulp; Soner Altiok; Eric B Haura
Journal:  J Thorac Oncol       Date:  2014-07       Impact factor: 15.609

4.  Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells.

Authors:  Yan Liu; Pui-Kai Li; Chenglong Li; Jiayuh Lin
Journal:  J Biol Chem       Date:  2010-06-18       Impact factor: 5.157

5.  HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.

Authors:  Nadire Duru; Ming Fan; Demet Candas; Cheikh Menaa; Hsin-Chen Liu; Danupon Nantajit; Yunfei Wen; Kai Xiao; Angela Eldridge; Brett A Chromy; Shiyong Li; Douglas R Spitz; Kit S Lam; Max S Wicha; Jian Jian Li
Journal:  Clin Cancer Res       Date:  2012-10-22       Impact factor: 12.531

Review 6.  The role of infectious agents in the etiology of ocular adnexal neoplasia.

Authors:  Varun Verma; Defen Shen; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 6.048

7.  Expression of interleukin-11 and interleukin-11 receptor alpha in human colorectal adenocarcinoma; immunohistochemical analyses and correlation with clinicopathological factors.

Authors:  Kazuyuki Yamazumi; Toshiyuki Nakayama; Takafumi Kusaba; Chun Yang Wen; Ayumi Yoshizaki; Yuichi Yakata; Takeshi Nagayasu; Ichiro Sekine
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

8.  Inflammation-associated serum and colon markers as indicators of dietary attenuation of colon carcinogenesis in ob/ob mice.

Authors:  Roycelynn A Mentor-Marcel; Gerd Bobe; Kathleen G Barrett; Matthew R Young; Paul S Albert; Maurice R Bennink; Elaine Lanza; Nancy H Colburn
Journal:  Cancer Prev Res (Phila)       Date:  2009-01

9.  Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.

Authors:  Hannes Steiner; Sonia Godoy-Tundidor; Hermann Rogatsch; Andreas P Berger; Dietmar Fuchs; Barbara Comuzzi; Georg Bartsch; Alfred Hobisch; Zoran Culig
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

10.  Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction.

Authors:  Svetlana A Tsareva; Richard Moriggl; Florian M Corvinus; Bernd Wiederanders; Alexander Schütz; Boris Kovacic; Karlheinz Friedrich
Journal:  Neoplasia       Date:  2007-04       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.